SCHEMBL8082013

SCHEMBL8082013

Nc1cc2c(Nc3ccc4[nH]ccc4c3)ncnc2cn1

nearest known ligand 0.74

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.74
FLT1 P17948 5/20 0.58
GRM1 Q13255 1/20 0.58
ERBB2 P04626 2/20 0.55
KDR P35968 2/20 0.54
RET P07949 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537238 0.86 EGFR (0.67) EGFRFLT1ERBB2KDRRET
SCHEMBL8093519 0.85 EGFR (1.00) EGFRFLT1ERBB2
SCHEMBL7535216 0.82 EGFR (0.65) EGFRFLT1ERBB2KDRRET
SCHEMBL7021509 0.81 EGFR (0.70) EGFRFLT1KDR
SCHEMBL7541823 0.80 EGFR (0.60) EGFRFLT1ERBB2KDRRET
SCHEMBL3606262 0.80 EGFR (0.73) EGFRFLT1ERBB2KDR
Hydrochloric Acid SCHEMBL7020471 0.80 EGFR (0.69) EGFRFLT1KDR
SCHEMBL1733829 0.80 EGFR (0.76) EGFRFLT1ERBB2KDRRET
SCHEMBL31514622 0.80 EGFR (0.69) EGFRFLT1ERBB2KDRRET
SCHEMBL27545981 0.80 EGFR (0.69) EGFRFLT1ERBB2KDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US claimed
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US disclosed
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed